Patent AnalyticsExaminers
Menu

Topic

Peptides immunotherapy Declining

472 applications whose title mentions it. Its share of new filings over the last two years is -87% below the four years before.

Allowance rate
77%
+1 pts vs the USPTO 454 decided
Months to first action
12.8 mo
−5.8 vs the USPTO
Applications
472.0
in the record
Allowed
348.0
106 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Applications

Recent applications on this topic

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19511603PEPTIDES DISPLAYED BY MHC FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCER2026-02-16Pending00n/a
18433852AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY NON-HLA-A*02 FOR U…2024-02-06Pending00n/a
18433894AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY NON-HLA-A*02 FOR U…2024-02-06Pending00n/a
15105281Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15410763Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15424759Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15719187Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15736847Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15941379Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15526382Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in